You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,993,470


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,993,470
Patent landscape, scope, and claims:
Title:Combination therapy
Abstract: Described herein are compounds and compositions for treating glaucoma and/or reducing intraocular pressure. Compositions may comprise an isoquinoline compound and a prostaglandin or a prostaglandin analog. Compounds described herein include those in which an isoquinoline compound is covalently linked to a prostaglandin or a prostaglandin analog, and those in which an isoquinoline compound and a prostaglandin free acid together form a salt.
Inventor(s): Kopczynski; Casey (Chapel Hill, NC), Lin; Cheng-Wen (Raleigh, NC), Sturdivant; Jill Marie (Chapel Hill, NC), deLong; Mitchell A. (Chapel Hill, NC)
Assignee: Aerie Pharmaceuticals, Inc. (Durham, NC)
Application Number:15/627,238
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,993,470

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Alcon Labs Inc ROCKLATAN latanoprost; netarsudil dimesylate SOLUTION/DROPS;OPHTHALMIC 208259-001 Mar 12, 2019 RX Yes Yes 9,993,470 ⤷  Subscribe Y Y REDUCTION OF ELEVATED INTRAOCULAR PRESSURE ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,993,470

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3461484 ⤷  Subscribe 301101 Netherlands ⤷  Subscribe
European Patent Office 3461484 ⤷  Subscribe 2021C/515 Belgium ⤷  Subscribe
European Patent Office 3461484 ⤷  Subscribe 132021000000068 Italy ⤷  Subscribe
European Patent Office 3461484 ⤷  Subscribe 122021000036 Germany ⤷  Subscribe
European Patent Office 3461484 ⤷  Subscribe C202130024 Spain ⤷  Subscribe
European Patent Office 3461484 ⤷  Subscribe 21C1024 France ⤷  Subscribe
European Patent Office 3461484 ⤷  Subscribe SPC/GB21/033 United Kingdom ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.